NuVasive
The Sponsor is conducting a survey to understand how parents or legal guardians feel about the benefits of using the Precice IMLL System to lengthen limbs in children who are 12 years old or younger.
All participants in this survey study will be the parent or legal guardian of a child who previously underwent surgery for limb length discrepancy according to the practitioner's standard of care, was 12 years of age or younger at the time of surgery, and is enrolled in the Precice IMLL arm in protocol NUVA.IMLL0723. The parent or legal guardian will be familiar with the patient's preoperative and postoperative condition, surgical treatment, postoperative care, and clinical outcomes. Each parent or legal guardian will complete the perceived clinical benefits survey questionnaire once. The sur…
Inclusion Criteria: * To be eligible for inclusion in this perceived clinical benefit survey study, the following inclusion criteria must be met: 1. Participants must be a parent or legal guardian of a subject already enrolled in the Precice IMLL arm of the study, "A Retrospective Review of the Clinical and Radiographic Outcomes Following the Use of the Precice Intramedullary Limb Lengthening System (IMLL) in Pediatric Limb Lengthening Procedures" (NUVA.IMLL0723). 2. The parent or legal guardian must be familiar with the patient's preoperative and postoperative condition, surgical treatm…
Parents or legal guardians of children that previously received the Precice IMLL will complete a survey. No additional or new interventions will be administered.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.